PBH
Price
$84.88
Change
-$0.61 (-0.71%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
3.6B
57 days until earnings call
ZTS
Price
$170.29
Change
+$0.87 (+0.51%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
77.48B
70 days until earnings call
Interact to see
Advertisement

PBH vs ZTS

Header iconPBH vs ZTS Comparison
Open Charts PBH vs ZTSBanner chart's image
Prestige Consumer Healthcare
Price$84.88
Change-$0.61 (-0.71%)
Volume$1.38K
Capitalization3.6B
ZOETIS
Price$170.29
Change+$0.87 (+0.51%)
Volume$24.57K
Capitalization77.48B
PBH vs ZTS Comparison Chart
Loading...
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PBH vs. ZTS commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PBH is a Buy and ZTS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (PBH: $84.87 vs. ZTS: $170.30)
Brand notoriety: PBH: Not notable vs. ZTS: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: PBH: 63% vs. ZTS: 97%
Market capitalization -- PBH: $3.6B vs. ZTS: $77.48B
PBH [@Pharmaceuticals: Other] is valued at $3.6B. ZTS’s [@Pharmaceuticals: Other] market capitalization is $77.48B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PBH’s FA Score shows that 1 FA rating(s) are green whileZTS’s FA Score has 0 green FA rating(s).

  • PBH’s FA Score: 1 green, 4 red.
  • ZTS’s FA Score: 0 green, 5 red.
According to our system of comparison, PBH is a better buy in the long-term than ZTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PBH’s TA Score shows that 5 TA indicator(s) are bullish while ZTS’s TA Score has 5 bullish TA indicator(s).

  • PBH’s TA Score: 5 bullish, 4 bearish.
  • ZTS’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ZTS is a better buy in the short-term than PBH.

Price Growth

PBH (@Pharmaceuticals: Other) experienced а -1.18% price change this week, while ZTS (@Pharmaceuticals: Other) price change was +2.43% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +13.58%. For the same industry, the average monthly price growth was +15.20%, and the average quarterly price growth was +63.51%.

Reported Earning Dates

PBH is expected to report earnings on Jul 31, 2025.

ZTS is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+13.58% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZTS($77.5B) has a higher market cap than PBH($3.6B). ZTS has higher P/E ratio than PBH: ZTS (32.94) vs PBH (14.90). PBH YTD gains are higher at: 8.682 vs. ZTS (4.650). ZTS has higher annual earnings (EBITDA): 3.67B vs. PBH (10.8M). ZTS has more cash in the bank: 2.04B vs. PBH (63.6M). PBH has less debt than ZTS: PBH (1.21B) vs ZTS (6.76B). ZTS has higher revenues than PBH: ZTS (8.54B) vs PBH (1.13B).
PBHZTSPBH / ZTS
Capitalization3.6B77.5B5%
EBITDA10.8M3.67B0%
Gain YTD8.6824.650187%
P/E Ratio14.9032.9445%
Revenue1.13B8.54B13%
Total Cash63.6M2.04B3%
Total Debt1.21B6.76B18%
FUNDAMENTALS RATINGS
PBH vs ZTS: Fundamental Ratings
PBH
ZTS
OUTLOOK RATING
1..100
1621
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
73
Overvalued
PROFIT vs RISK RATING
1..100
765
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4751
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
1455

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZTS's Valuation (73) in the Pharmaceuticals Generic industry is in the same range as PBH (83) in the Pharmaceuticals Other industry. This means that ZTS’s stock grew similarly to PBH’s over the last 12 months.

PBH's Profit vs Risk Rating (7) in the Pharmaceuticals Other industry is somewhat better than the same rating for ZTS (65) in the Pharmaceuticals Generic industry. This means that PBH’s stock grew somewhat faster than ZTS’s over the last 12 months.

PBH's SMR Rating (100) in the Pharmaceuticals Other industry is in the same range as ZTS (100) in the Pharmaceuticals Generic industry. This means that PBH’s stock grew similarly to ZTS’s over the last 12 months.

PBH's Price Growth Rating (47) in the Pharmaceuticals Other industry is in the same range as ZTS (51) in the Pharmaceuticals Generic industry. This means that PBH’s stock grew similarly to ZTS’s over the last 12 months.

PBH's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as ZTS (100) in the Pharmaceuticals Generic industry. This means that PBH’s stock grew similarly to ZTS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PBHZTS
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
64%
Momentum
ODDS (%)
Bearish Trend 2 days ago
56%
Bullish Trend 2 days ago
60%
MACD
ODDS (%)
Bearish Trend 2 days ago
62%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
53%
Bullish Trend 2 days ago
61%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
60%
Advances
ODDS (%)
Bullish Trend 5 days ago
59%
Bullish Trend 2 days ago
58%
Declines
ODDS (%)
Bearish Trend 14 days ago
52%
Bearish Trend 14 days ago
55%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
38%
Aroon
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRAR1.690.17
+11.18%
Glimpse Group (The)
CRC44.990.82
+1.86%
California Resources Corp
TU16.490.10
+0.61%
Telus Corp
BHLB24.46-0.30
-1.21%
Berkshire Hills Bancorp
BLFY8.88-0.18
-1.99%
Blue Foundry Bancorp

ZTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZTS has been loosely correlated with VTRS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ZTS jumps, then VTRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
+0.47%
VTRS - ZTS
44%
Loosely correlated
-1.14%
AMRX - ZTS
38%
Loosely correlated
+1.37%
PAHC - ZTS
37%
Loosely correlated
+0.66%
ELAN - ZTS
37%
Loosely correlated
-0.15%
PBH - ZTS
36%
Loosely correlated
-0.21%
More